-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
-
Summary
-
CNS Pharmaceuticals, Inc. quarterly Preferred Stock, Shares Issued history and growth rate from Q4 2018 to Q2 2024.
- CNS Pharmaceuticals, Inc. Preferred Stock, Shares Issued for the quarter ending June 30, 2024 was 0 shares.